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Abstract. We have used immunohistochemical  tech- 
niques to detect transforming growth factor-ill  (TGF- 
/31) in many tissues of adult and neonatal mice.  Each 
of two antibodies raised to the amino-terminal  30 
amino acids of TGF-fll  selectively stained this mole- 
cule in either intracellular  or extracellular locations. 
Strong intracellular  staining  was found in adrenal  cor- 
tex, megakaryocytes and other cells of the bone mar- 
row,  cardiac myocytes, chondrocytes, renal distal tu- 
bules, ovarian glandular cells, and chorionic cells of 
the placenta.  Marked staining of extracellular matrix 
was found in cartilage,  heart,  pancreas,  placenta,  skin, 
and uterus.  Staining  was often particularly  intense in 
specialized cells of a given tissue,  suggesting unique 
roles for TGF-fl within that tissue.  Levels of expres- 
sion of mRNA for TGF-fll and its histochemical stain- 
ing did not necessarily correlate in a given tissue, as 
in the spleen. The present data lend further support to 
the concept that TGF-fl has an important  role in con- 
trolling  interactions between epithelia and  surrounding 
mesenchyme. 
I 
N the preceding paper (Flanders  et al.,  1989),  we have 
described the use of two antibodies,  anti-CC(1-30) and 
anti-LC(1-30),  for histochemical  localization  of trans- 
forming growth factor-/31 (TGF-fll),~ with the former stain- 
ing predominantly  extracellularly  and the latter  intracellu- 
larly.  We now report the use of these two antibodies  in a 
histochemical  survey of numerous tissues  of neonatal  and 
adult mice.  Furthermore, we have performed Northern blot 
analysis on many of these mouse tissues to determine if the 
level of mRNA expression correlates with the intensity  of 
histochemical  staining, since it has been previously reported 
that there may be poor correlation between mRNA levels and 
levels of expressed protein when measurements  of TGF-fl are 
made on cultured cells (Kehrl et al.,  1986; Assoian  et al., 
1987). 
Materials and Methods 
Immunohistochemistry 
Rabbit polyclonal antibodies to unconjugated peptides corresponding to the 
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1. Abbreviations used in this paper: GAPDH, glyceraldehyde-3-phosphate 
dehydrogenase; TGF-fl, transforming growth factor-/K 
amino-terminal  30  amino  acids  of TGF-/$1 were  prepared  as  described 
(Flanders et al., 1989). Tissues from 6-8-wk-old adult or 4-5-d-old neona- 
tal NIH-Swiss mice were excised immediately after death by carbon dioxide 
and fixed by immersion overnight at room temperature in neutral-buffered 
formalin. Tissues were also obtained from adult mice anesthetized with so- 
dium pentobarbital. Blood was cleared by brief  cardiac perfusion with PBS, 
followed by formalin fixation in situ for 20 min. Tissue was postfixed in 
Bouin's solution for an additional 4-6 h, transferred to 70% ethanol, embed- 
ded in paraffin, and sectioned at 5 t~m. Rib specimens were decalcified be- 
fore embedding. TGF-/~I was localized in tissue sections using avidin-bio- 
tin-peroxidase or avidin-biotin-alkaline phosphatase as described (Flanders 
et al., 1989). Details of controls are given in the accompanying manuscript 
(Flanders et al.,  1989). 
RNA Extraction and Northern Hybridization 
Total RNA was prepared according to Chirgwin et al.  (1979) from tissues 
that were flash frozen in liquid nitrogen and stored at -70°C. 10 ~g of total 
RNA per lane was subjected to electrophoresis  in formaldehyde-agarose 
gels and transferred to Nytran filters (Davis et al., 1986). Filters were hy- 
bridized  according  to  Church  and  Gilbert  (1984),  using  a  32p-labeled, 
single-strand, cDNA probe for TGF-fll and a nick-translated cDNA probe 
for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Van  Obberghen- 
Schilling et al.,  1988). 
Results 
I~ssue Distribution of TGF-~I 
Table I presents a summary of the tissue distribution  of im- 
munohistochemically  detectable TGF-fll in adult mouse tis- 
sues, using both anti-LC(1-30) and anti-CC(1-30) antibod- 
ies. Relative staining intensity on a scale of 1-4+ was judged 
subjectively by the density of the peroxidase reaction product 
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Detectable  TGF-f31 in Adult Mouse 
Antibody 
Anti-LC  Anti-CC 
Tissue  Localization  (1-30)  (I-30) 
Adrenal  Adrenocortical cells  + + +  - 
Bone marrow  Hematopoietic cords,  + +  - 
megakaryocytes 
Brain  ND*  -  - 
Cartilage  Chondrocytes  + + +  - 
Matrix  -  + + 
Heart  Cardiac myocytes  + +  - 
Interstitial connective tissue  -  + + 
Intestine  Mucosal epithelium  +  - 
Kidney  Distal tubules  + + + +  - 
Liver  Biliary ductular cells,  +  - 
hepatocytes 
Lung  Bronchial epithelial cells  +  - 
Pancreas  Periductular connective tissue  -  + + + + 
Ovary  Interstitial glandular cells  + +  - 
Placenta  Chorion (subpopulation)  + + + +  - 
Peri-chorionic connective tissue  -  + + 
Skin  Epidermis  +  - 
Papillary dermis  -  + + 
Spleen  ND  + / -  - 
Testes  ND  -  - 
Uterus  Periglandular connective tissue  -  + + + 
* None detected above background staining level of normal rabbit IgG with 
either anti-LC (1-30) or anti-CC (1-30). 
and more quantitatively  by the persistence of staining with 
increasing antibody dilution. 
Using anti-LC(1-30), intracellular staining of specific cell 
types was seen in many adult tissues (Table I). With our fixa- 
tion and staining protocol and a primary antibody concentra- 
tion of 20 t~g/ml, the intensity of staining varied substantially 
between cell types. Intense cytoplasmic staining was found 
in costal  chondrocytes,  renal  distal  tubule  cells,  placental 
chorion cells near the site of implantation, and adrenal corti- 
cal cells.  Moderate  staining  was  seen in cardiac myocytes 
and cells of the bone marrow, while lighter staining occurred 
in such cell types as intestinal epithelial cells and biliary duc- 
tular cells. By contrast, no specific intracellular staining was 
seen in brain or pancreas. 
Anti-CC(1-30) gives discrete extracellular tissue localiza- 
tion  of TGF-/31.  In some cases,  this  extracellular  staining 
occurs near cells which are stained intracellularly  by anti- 
LC(I-30), as occurs in placenta, cartilage, and heart.  How- 
ever, in other cases, such as uterus and pancreas, staining of 
stroma is seen without detectable intracellular staining of any 
cell type by anti-LC(1-30).  Conversely, cells of the adrenal 
cortex,  renal  distal  tubules,  and ovarian interstitial  glands 
display intracellular staining with anti-LC(1-30) without de- 
tectable extracellular  staining by anti-CC(1-30). 
Specific features of the staining patterns of TGF-B1 in sev- 
eral tissues, controls to show antibody specificity, and com- 
parisons between adult and neonatal tissue are presented be- 
low. This survey is intended as an overview of the cellular 
distribution of TGF-131 which may suggest potential tissue- 
specific roles, rather than as an exhaustive examination of ev- 
ery murine cell type. 
Adrenal Tissue 
Anti-LC(1-30) stains cytoplasm in the adult adrenal cortex 
(Fig.  1 A), primarily in the inner two cortical subdivisions, 
zona fasciculata and zona reticularis.  A small subpopulation 
of pheochromocytes (neural  crest-derived)  in  the  adrenal 
medulla is also stained by this antibody. Specificity of stain- 
ing was demonstrated by blocking of antibody with TGF-/31 
coupled to Sepharose as described  (Flanders  et al.,  1989) 
(Fig.  1 B). Equivalent blocking was also obtained by prein- 
cubation of antibody in solution with peptide LC(1-30) (not 
shown). TGF-/31 reactive with anti-CC(1-30) was not found 
in any adrenal cell type. 
Hematopoietic Tissue 
Anti-LC(1-30) stains megakaryocytes and other cells of the 
hematopoietic cords in red bone marrow of the adult rib (Fig. 
2 A).~ Interestingly, this antibody stained the multilobulated 
megakaryocyte nucleus at a stage when platelets were not yet 
visible in the cytoplasm. Whether this intense staining of the 
megakaryocyte nucleus  is  related  to its  peculiar  polyploid 
(up to 32 or 64 n) state remains to be determined;  it is in- 
teresting to note that anti-LC(1-30) did not stain the nucleus 
of any other tissue  or cell  type.  The  identity  of the other 
hematopoietic  precursor  cell  types  was  not  determined. 
Specificity of staining was demonstrated on sequential  sec- 
tions by blocking antibody staining with peptide LC(1-30) in 
solution at a 20-fold molar excess of peptide over IgG (Fig. 
2 B).  I The same staining pattern was obtained with an alka- 
line  phosphatase  detection  system  (not shown),  indicating 
that iron complexes such as hemosiderin,  which are abun- 
dant in red marrow, did not give false positive staining in our 
experiments  (Sternberger,  1986).  Although Ellingsworth et 
al.  (1986)  reported  a  similar  localization  of TGF-/~l  with 
anti-CC(1-30) in fetal bovine bone marrow, no staining was 
observed in the mouse using the present  staining protocol 
with this antibody. 
In vitro studies have shown that TGF-~ inhibits prolifera- 
tion of hematopoietic progenitor cells stimulated by interleu- 
Figure 1. Immunolocalization of TGF-/3 in adult mouse adrenal  gland.  (A) Anti-LC(1-30) stains adrenal  cortex, predominantly zona fas- 
ciculata  (f) and zona reticularis  (r).  In addition,  light staining  is seen in a subpopulation  of pheochromocytes in the medulla  (m).  Inset 
shows cytoplasmic localization and heterogeneity  of staining in zona reticularis  at higher magnification.  Avidin-biotin-peroxidase detection 
system.  Giemsa and May-Grunwald counterstains.  (B) Staining is blocked in this control sequential  section, stained with an equivalent 
aliquot  of antibody preadsorbed with Sepharose to which TGF-B had been coupled. Bars:  (A and B)  100 ~m; (inset) 10 #m. 
Figure 2. TGF-/3 in bone marrow. (A) Section through bone marrow of adult mouse rib. Anti-LC(1-30) stains megakaryocyte nuclei (arrows) 
and cells of the hematopoietic  cords.  (B) Control sequential  section stained with antibody which had been blocked by preincubation with 
a 20-fold molar excess of peptide  LC(I-30). Avidin-biotin-peroxidase, with Giemsa and May-Grunwald counterstains.  Bar,  100/.tm. 
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matopoiesis also occurs in spleen, little or no staining above 
background level was observed in this tissue in neonate or 
adult (not shown). Likewise, no staining was detected in the 
hematopoietic cells which are Still present in neonatal liver 
at 4 d after birth or in gut-associated lymphoid tissue (not 
shown). 
Heart 
Cardiac myocytes are uniformly stained by anti-LC(1-30) in 
both the adult and neonate with somewhat greater intensity 
in the atria than in the ventricles (Fig. 3, A and D). Antibody 
to CC(1-30), by contrast, stains the fibrous cardiac skeleton 
(to which cardiac muscles and valves are both anchored), as 
well as the valves themselves (Fig. 3, B and E). In the em- 
bryo, anti-CC(1-30) stained endocardial cushion tissue and 
developing heart valves (Heine et al.,  1987). 
Kidney 
A subpopulation of distal tubule cells in both neonatal and 
adult kidney is intensely stained by anti-LC(1-30) (Fig. 4, 
A and B). Staining is confined to the cortex; none is seen in 
the collecting ducts that penetrate the medulla. This localiza- 
tion of  TGF-/31 is similar to that reported for EGF in the adult 
mouse kidney by immunohistochemical (Salido et al., 1986) 
and in situ hybridization (Rail et al., 1985) techniques. EGF, 
however, is not detectable in the kidney until "o2 wk after 
birth (Popliker et al., 1987) and is localized in the apical por- 
tions of the cells (Salido et al.,  1986) in contrast to the uni- 
Figure 3. TGF-/3  in adult (A-C)  and neonatal (D-F)  mouse heart ventricle. (A and D) Anti-LC(l-30) stains cytoplasm of all cardiac myocytes 
(m). (B and E) Anti-CC(1-30)  stains interstitial connective tissue around capillaries and connective tissue of valve leaflets (v). (C and 
F) Treatment with nonimmune rabbit IgG at the same concentration gives no staining on sequential sections. Peroxidase, with Giemsa 
and May-Grunwald counterstains. Bars, 100 #m. 
The Journal of Cell Biology,  Volume 108, 1989  664 Figure 4. TGF-/3 in adult and neonatal kidney. (/t and B) Anti-LC(1-30) stains a subpopulation of distal tubule cells in the adult mouse 
cortex. (B) Higher magnification of A reveals heterogeneity of staining within proximal distal tubule. (C) Anti-CC(1-30) does not stain 
adult mouse kidney. (D) Anti-CC(1-30) stains connective tissue of neonatal kidney in vicinity of cortical-medullary junction (arrow). Per- 
oxidase, with Giemsa and May-Grunwald counterstains. Bars, 100 #m. 
form distribution of TGF-fll throughout the cytoplasm. Due 
to the especially intense immunoreactivity of kidney tissue 
with anti-LC(1-30), it was necessary to dilute primary anti- 
body preparations to <1 #g/ml IgG for blocking reactions. 
Preincubation of antibody with peptide LC(1-30) at a 400- 
fold molar excess greatly reduced staining, whereas preincu- 
bation with a nonhomologous peptide at the same concentra- 
tion did not (not shown). Anti-CC(1-30) has little reactivity 
in adult kidney (Fig. 4  C), but does stain a fine network of 
interstitial tissue prominent at the cortical-medullary junc- 
tion in the neonate (Fig. 4 D). 
Placenta 
We examined TGF-/31 immunolocalization in placenta at 15 
and 18 d of gestation. At both times, anti-LC(1-30) stained 
cells of the chorion at the interface between the implantation 
site and the rest of  the chorion (Fig. 5 A). Placental morphol- 
ogy varies greatly between species, with a disc-shaped area 
of fusion present in rodents (Banks,  1986).  The maternal 
portion of the chorion was not stained by anti-LC(1-30). 
Anti-CC(1-30)  weakly stained  fine  connective tissue be- 
tween the chorion and adjacent blood vessels (Fig. 5 B). The 
placenta continuously undergoes changes in size, shape, and 
internal structure during gestation (Bjorkman and Dantzer, 
1987),  and TGF-~I may play a regulatory role during this 
remodeling. 
Other Organs and Tissues 
As noted in Table I, immunoreactive TGF-/31 is present in 
several other sites. Anti-LC(1-30) stains interstitial glandu- 
lar cells of the ovary (Fig. 5, C and D), while anti-CC(1-30) 
stains stroma in adult uterine glands (not shown), suggesting 
a role in reproductive physiology (Feng et al., 1988; Skinner 
et al.,  1987).  We did not examine variations during the es- 
trous cycle. The cytoplasm of chondrocytes in adult and neo- 
natal  cartilage is  intensely stained by anti-LC(1-30)  (not 
shown), as was also seen in embryonic cartilage (Flanders 
et al., 1989). In some organs such as stomach, liver, and eye, 
it was difficult  to interpret antibody reactivity due to nonuni- 
form staining patterns and high background with nonim- 
mune rabbit IgG. In adult liver, light staining of hepatocytes, 
especially near central veins,  and of biliary ductular cells 
with anti-LC(1-30) (not shown) may reflect hepatic uptake 
and processing of TGF-fll (Coffey et al.,  1987).  Other or- 
gans,  such as adult brain,  are clearly negative under our 
staining conditions. 
TGF-/?I RNA Expression 
To correlate expression of TGF-/31 protein as detected by im- 
munohistochemical staining with steady-state levels of TGF- 
/31 message, total RNA was prepared from several  normal 
murine tissues and RNA Northern blots were hybridized to 
Thompson et al.  Cell Type-specific Expression of TGF-/Yl  665 Figure 5. TGF-/3  in mouse placenta and ovary. (A) Placenta at 18 d of gestation stained with Anti-LC(1-30).  Cytoplasm of chorion cells 
near site of implantation is intensely positive. (B) Anti-CC(1-30) stains stroma between chorion and blood vessels in an adjacent placental 
section. Giemsa and May-Grunwald counterstains. (C and D) Adult mouse ovary. (C) Anti-LC(1-30)  stains interstitial glandular cells. 
Staining of developing ova (arrows) was artifactual and could not be competed by peptide. (D) Higher magnification of C showing specific 
cytoplasmic staining of interstitial glandular cells. Peroxidase, with methyl green counterstain. Bars, 100 #m. 
a single-stranded cDNA probe for TGF-/~I. The 2.4-kb TGF- 
/31 transcript is detectable in all tissues examined (Fig. 6 A). 
The lowest levels of TGF-/31 RNA are found in normal adult 
liver and skin, tissues which give light but detectable anti- 
body staining. The highest level of TGF-/31 RNA expression 
is  seen in  adult  spleen;  steady-state levels (quantitated by 
densitometry) are "~15-fold greater than those in liver. De- 
spite the abundance of TGF-fll RNA however, little or no 
TGF-~ was detected in this organ with either anti-LC(1-30) 
or anti-CC(1-30). Since the original tissue samples for RNA 
analysis and immunohistochemistry were taken from differ- 
ent animals, it was possible that this lack of correlation was 
due to an unapparent infection or some other interanimal 
variation. Therefore, we divided the spleens of three addi- 
tional adult mice for RNA and immunohistochemical prepa- 
rations. High steady-state levels of TGF-/31 RNA, compara- 
ble to those initially observed, were again found in all three 
spleens (Fig. 6 C), yet no staining above background levels 
was detected by immunohistochemistry. Intermediate levels 
of TGF-~I RNA expression were found in adult heart, kid- 
ney, small intestine, adrenal, placenta (15-d gestation), and 
colon (Fig. 6 A). Steady-state mRNA levels in these organs 
relative to adult liver are five-,  four-, four-, two-, five-, and 
twofold, respectively. Ethidium bromide staining confirmed 
that RNA loading was similar in all lanes (Fig. 6 B). 
TGF-/~I RNA expression in neonatal vs.  adult tissue was 
compared for heart, kidney, small intestine, and liver (Fig. 
7 A). Steady-state message levels for the constitutive glyco- 
lytic enzyme GAPDH were used to standardize RNA loading 
(Fig. 7 B). When standardized to GAPDH, levels of the 2.4- 
kb TGF-ffl transcript in heart and small intestine vary less 
than twofold between neonate and adult. Adult heart RNA 
however has two additional TGF-~ species of ~1.1 and 0.8 
kb, which hybridize to the cDNA probe and are not seen in 
neonatal heart tissue. The abundance of these RNAs is 0.2- 
and 0.5-fold, respectively, relative to the 2.4-kb transcript. 
When standardized to GAPDH, neonatal liver TGF-ffl RNA 
expression is twofold higher than in adult liver, while neona- 
tal kidney RNA expression is approximately fourfold higher 
than in adult kidney. 
Discussion 
We have demonstrated the presence of immunoreactive TGF- 
/31  in  many neonatal and  adult murine tissues,  using  two 
different antibodies raised to the amino-terminal 30 amino 
acids of TGF-/31. Marked staining is found in tissues from 
which TGF-~I has been purified to homogeneity, such as kid- 
ney (Roberts et al., 1983) and placenta (Frolik et al., 1983). 
Staining is associated with particular cell types and is spe- 
cific. Staining with anti-LC(1-30) is intracellular in epithe- 
lial  (e.g.,  renal  distal  tubule),  mesenchymal (e.g.,  costal 
chondrocyte), and hematopoietic (e.g., megakaryocyte) cell 
types, while staining with anti-CC(1-30) is extracellular and 
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TGF-h'I mRNA in adult mouse 
tissues.  (A) Northern  blot of 
total RNAs (10 #g/lane) hybrid- 
ized to human TGF-~ probe. 
(B) Ethidium bromide-stained 
Nytran blot shown in A before 
hybridization.  (C)  Northern 
blot of total spleen RNAs (10 
#g/lane) from three additional 
normal adult mice (lanes 1-3) 
and spleen RNA shown in A 
(lane 4); hybridized as in A. 
(D) Blot shown in C hybrid- 
ized to probe for GAPDH. 
associated  with  mesenchyme in  every case  (e.g.,  uterine 
stroma). Differences in primary epitope specificity appear to 
account for the differential staining pattern (Flanders et al., 
1989), and as such, these polyclonal antibodies are function- 
ally more analogous to monoclonal antibody preparations, 
recognizing a possible conformational change between intra- 
cellular and extracellular forms of TGF-I~I. 
Specificity of staining has been demonstrated by blocking 
with TGF-fll or peptide and lack of reactivity with nonim- 
mune IgG. The amino-terminal 30 amino acid sequence of 
TGF-/~I is completely conserved between human and mouse 
(Derynck et al., 1986). Computer search of  this sequence re- 
veals no homology with five or more adjacent amino acids 
of any protein in the database with the exception of TGF-~2 
(deMartin et al.,  1987;  Marquardt et al.,  1987),  TGF-/33 
(Jakowlew et al.,  1988a; ten Dijke et al.,  1988), or TGF-/34 
(Jakowlew et al.,  1988b) making it unlikely that cross-reac- 
tivity with other proteins is responsible for the staining pat- 
terns. 
The proportion of staining which represents latent, precur- 
Figure 7. Comparison of steady-state levels of TGF-~I 
RNA in adult (A) and neonatal (N) mouse tissues. (A) 
Northern blot of total RNAs (10 #g/lane) hybridized  to 
human TGF-fll probe. (B) Blot shown in A hybridized 
to probe for GAPDH. 
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hybridization data are needed to correlate protein staining 
with sites of synthesis. Our localization of TGF-/$1 in the 
epidermis of mouse skin with anti-LC(1-30) correlates well 
with the recently reported localization of TGF-/31 mRNA to 
the suprabasal  epithelial layer in mouse skin treated with 
phorbol ester (Akhurst et al., 1988) and suggests that this an- 
tibody recognizes TGF-/31 at sites of synthesis. 
Our Northern blot analysis of  murine tissue RNAs demon- 
strates that TGF-/5'I mRNA is detectable in every tissue ex- 
amined; however, levels of this RNA do not correlate with 
the distribution of immunoreactive TGF-fll. In particular, 
high  levels  of TGF-~I  mRNA  are  expressed  in  normal 
spleen, yet no staining above background levels was detected 
by either anti-LC(1-30) or anti-CC(1-30). Possible explana- 
tions for this discrepancy could include (a) protein levels be- 
low the detection limits of our assay, (b) lability or masking 
of epitopes in spleen (by a binding protein for example), or 
(c)  failure of TGF-fll  mRNA to  be  translated in  spleen. 
Studies  reported  by others  in  lymphocytes (Kehrl et al., 
1986) and macrophages (Assoian et al.,  1987) have shown 
that TGF-~'I  mRNA may be expressed without detectable 
protein secretion.  Conversely, positive staining in splenic 
macrophages can be induced by immunization of animals 
with bacterial cell walls with no concurrent change in splenic 
TGF-/31 mRNA levels  (Wahl et al.,  1988). 
The cellular distribution of TGF-B1 in vivo may reflect im- 
portant mechanisms of action in some tissues. Regulation of 
steroid synthesis may be a principal physiological role. In 
vitro studies have shown that TGF-B1 is a potent modulator 
of differentiated adrenalcortical cell function; it inhibits bas- 
al steroidogenesis, as well as that induced by angiotensin II 
or ACTH (Feige et al.,  1986;  Hotta and Baird,  1986) and 
decreases  angiotensin II-receptor  numbers  (Feige  et  al., 
1987).  In vitro TGF-/Yl suppresses cortisol synthesis (Feige 
et al.,  1987),  which is confined to the zona reticularis and 
fasciculata. Our localization of TGF-/$1 in these adrenal cor- 
tical zones is thus consistent with Hotta and Baird's (1986) 
suggestion that TGF-fll plays a role in maintaining homeosta- 
sis in this organ.  Placental chorion cells (Ferguson et al., 
1986)  and renal  distal  tubule cells  (Sasano et al.,  1988) 
are also known to possess steroidogenic enzyme activities 
and all contain immunoreactive TGF-~I. Ovarian granulosa 
cells and testicular steroid-producing cells were negative, 
however. 
Neonatal  and  adult  tissue-staining  patterns  were  com- 
pared in kidney, skin, heart, spleen, pancreas, cartilage, in- 
testine, and liver. In all cases, neonatal staining patterns cor- 
responded to those reported  for adult tissues  in  Table  I, 
although some variation in staining intensity was observed. 
As reported above, adult heart contains two RNA species of 
0.8 and 1.1 kb that hybridize to the TGF-/31 probe and are not 
detected in the 5-d-old neonate. A novel TGF-ffl transcript 
of ,,ol.0 kb has been observed in porcine heart, which may 
represent an alternatively spliced messenger (Kondaiah et 
al.,  1988).  Hybrid selection and in vitro translation experi- 
ments are in progress to determine if the specific RNAs in 
the adult mouse heart encode unique proteins. A unique role 
for TGF-/~I in the heart is not known, although the peptide 
elevates actin mRNA in cell culture (Leof et al.,  1986),  a 
regulatory role which may be important in cardiac muscle. 
In summary, we have found immunoreactive intracellular 
and extraceUular TGF-fll in a wide variety of murine tissues. 
Staining is often particularly intense in specialized cells within 
a given tissue. The present results add further confirmation 
to previous  suggestions (Heine et al.,  1987; Lehnert and 
Akhurst, 1988) that TGF-/~ plays an important role in con- 
trolling interactions between epithelia and surrounding mes- 
enchyme. Our studies also suggest that there may be new 
functions,  as  yet undetermined,  for  TGF-~  in  particular 
cells, such as cardiac myocytes and renal tubular cells. Fur- 
ther studies on the role of TGF-/$ in the pathogenesis of dis- 
ease in specific organs may be particularly useful in elucidat- 
ing the function of this peptide in normal cells and tissues. 
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